Abiopharma

🔍 WestCap Management, LLC (Executive)

Company: StubHub Holdings, Inc. (STUB)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Acquired 6,256,893 shares of Class A Common Stock at $23.5 per share (Direct)
  Date: 2026-03-17 | Code: C | equity_swap_involved: 0 | shares_owned_after: 37,991,583.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 6,256,893 shares of Series O Preferred Stock, par value $0.001 per share at $23.5 per share (Derivative)
  Date: 2026-03-17 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F5, F2

Footnotes:

• F1: The securities reported on this line are held directly by WestCap Stub Holdco 2024, LLC ("WestCap Stub") and WestCap StubHub Opportunity Fund Preferred, LLC ("WestCap StubHub").
• F2: The securities reported on this line were held directly by WestCap StubHub.
• F3: WestCap Management, LLC ("WestCap") is the managing member of WestCap Stub and WestCap StubHub. Laurence A. Tosi may be deemed to hold voting and investment control over the shares held by WestCap Stub and WestCap StubHub. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.
• F4: The Series O Preferred Stock automatically converted into Class A Common Stock, par value $0.001 per share ("Class A Common Stock") on March 17, 2026, the date that is 180 days after the closing on September 18, 2025 of the issuer's initial public offering.
• F5: The Series O Preferred Stock had no stated maturity.